Caporali R, Ravasio R, Raimondo P, Salaffi F. Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy. Grhta [Internet]. 2022 Feb. 17 [cited 2024 Jul. 3];9(1):30. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2383